These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 3597311)

  • 21. Magnetic resonance imaging of the prostate.
    Iversen P; Kjaer L; Thomsen C; Henriksen O
    Scand J Urol Nephrol Suppl; 1987; 104():41-5. PubMed ID: 3481468
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Histological diagnosis of prostatic carcinoma on biopsy specimens (author's transl)].
    Harada M
    Rinsho Byori; 1978 Oct; 26(10):877-84. PubMed ID: 81895
    [No Abstract]   [Full Text] [Related]  

  • 23. [Prostatic pathology imaged by magnetic resonance. 58 cases].
    Gevenois PA; Van Regemorter G; Van Gansbeke D; Delcour C; Corbusier A; Struyven J
    J Radiol; 1987 Mar; 68(3):185-92. PubMed ID: 2439686
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The abnormal prostate: MR imaging at 1.5 T with histopathologic correlation.
    Carrol CL; Sommer FG; McNeal JE; Stamey TA
    Radiology; 1987 May; 163(2):521-5. PubMed ID: 2436253
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Magnetic resonance tomography in prostatic carcinoma and benign prostatic diseases with an endorectal and a new combined endorectal body phased-array coil].
    Engelhard K; Hollenbach HP; Ott G; Hausmann J; Risse W; Riedl C
    Rontgenpraxis; 1999; 52(7):214-23. PubMed ID: 10605323
    [No Abstract]   [Full Text] [Related]  

  • 26. Editorial comment on: Combined magnetic resonance imaging and magnetic resonance spectroscopy imaging in the diagnosis of prostate cancer: a systematic review and meta-analysis.
    Seitz M; Gratzke C
    Eur Urol; 2009 Mar; 55(3):591. PubMed ID: 18952366
    [No Abstract]   [Full Text] [Related]  

  • 27. Localising prostate cancer: comparison of endorectal magnetic resonance (MR) imaging and 3D-MR spectroscopic imaging with transrectal ultrasound-guided biopsy.
    Goris Gbenou MC; Peltier A; Addla SK; Lemort M; Bollens R; Larsimont D; Roumeguère T; Schulman CC; van Velthoven R
    Urol Int; 2012; 88(1):12-7. PubMed ID: 22004874
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The ORL area as the seat of metastases. A case report of mandibular metastasis of adenocarcinoma of the prostate gland].
    Mompó Romero L; Faubel Serra M; Pons Rocher F; Guallart Doménech F
    An Otorrinolaringol Ibero Am; 1994; 21(3):223-30. PubMed ID: 8037364
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Endorectal magnetic resonance imaging for staging of prostatic cancer].
    Hayashi N; Kawamura J; Sugimura Y
    Hinyokika Kiyo; 1996 Oct; 42(10):767-73. PubMed ID: 8951473
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Magnetic resonance spectroscopic imaging: current status in the management of prostate cancer.
    Nayyar R; Kumar R; Kumar V; Jagannathan NR; Gupta NP; Hemal AK
    BJU Int; 2009 Jun; 103(12):1614-20. PubMed ID: 19338548
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MR imaging and MR spectroscopy in prostate cancer management.
    Katz S; Rosen M
    Radiol Clin North Am; 2006 Sep; 44(5):723-34, viii. PubMed ID: 17030223
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 3D MR spectroscopic imaging in the evaluation of prostate cancer.
    Rajesh A; Coakley FV; Kurhanewicz J
    Clin Radiol; 2007 Oct; 62(10):921-9. PubMed ID: 17765456
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Leiomyosarcoma of the rectum versus prostatic malignancy. Differentiation by magnetic resonance imaging.
    Hamlin DJ; Pettersson H; Wajsman Z; Bland K; Hackett RL
    Rofo; 1985 Oct; 143(4):482-4. PubMed ID: 2997885
    [No Abstract]   [Full Text] [Related]  

  • 34. [Cancer of the prostate. Computed tomography and magnetic resonance imaging in the assessment of extracapsular extension].
    Quintens H; Chevallier D; Padovani B; Michels JF; Amiel J; Toubol J
    J Urol (Paris); 1990; 96(4):207-9. PubMed ID: 2212718
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Urology imaging: contribution of imaging in prostatic cancer].
    Descotes JL; Hubert J; Rouvière O; Artignan X
    Prog Urol; 2003 Nov; 13(5):843-84. PubMed ID: 14763387
    [No Abstract]   [Full Text] [Related]  

  • 36. Imaging of recurrent prostate cancer.
    Fütterer JJ
    Radiol Clin North Am; 2012 Nov; 50(6):1075-83. PubMed ID: 23122039
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prostatic adenocarcinoma presenting with metastatic frontal bone involvement and orbital invasion.
    Patel V; Castell FA; Akinwunmi J; Francis I; Chandrasekharan L; Malhotra R
    Orbit; 2010 Aug; 29(4):213-5. PubMed ID: 20812840
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Combined magnetic resonance imaging and spectroscopy in the assessment of high grade prostate carcinoma in patients with elevated PSA: a single-institution experience of 356 patients.
    Villeirs GM; De Meerleer GO; De Visschere PJ; Fonteyne VH; Verbaeys AC; Oosterlinck W
    Eur J Radiol; 2011 Feb; 77(2):340-5. PubMed ID: 19740617
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The expanding role of MRI in prostate cancer.
    Murphy G; Haider M; Ghai S; Sreeharsha B
    AJR Am J Roentgenol; 2013 Dec; 201(6):1229-38. PubMed ID: 24261361
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Diagnosis of prostate capsular invasion by pelvic magnetic resonance imaging and serum level of prostate specific antigen].
    Mikata K; Uemura H; Fujinami K; Ohuchi H; Miyoshi Y; Ohta J; Osada Y; Jinza S; Kubota Y; Hosaka M; Nakatani I; Takebayashi S
    Hinyokika Kiyo; 2001 Jun; 47(6):385-8. PubMed ID: 11496393
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.